Unique stem cell line identifier | TRNDi009-C |
Alternative name(s) of stem cell line | HT220C |
Institution | National Institutes of Health National Center for Advancing Translational Sciences Bethesda, Maryland, USA |
Contact information of distributor | Dr. Wei Zheng; Wei.Zheng@nih.gov |
Type of cell line | iPSC |
Origin | Human |
Additional origin info | Age: 21-fetal-week-old Sex: Female Ethnicity: Caucasian |
Cell Source | Fibroblasts |
Clonality | Clonal |
Method of reprogramming | Integration-free Sendai viral vectors |
Genetic Modification | NO |
Type of Modification | N/A |
Associated disease | Niemann-Pick disease Type A (NPA) |
Gene/locus | Gene: SMPD1 Locus: 11p15.4 Mutation: p. L302P (c.905 T > C) |
Method of modification | N/A |
Name of transgene or resistance | N/A |
Inducible/constitutive system | N/A |
Date archived/stock date | 2018 |
Cell line repository/bank | N/A |
Ethical approval | NIGMS Informed Consent Form was obtained from patient at time of sample submission. Confidentiality Certificate: CC-GM-15–004 |